ArticleFrontiers in oncology2025
Predictive factors for outcome in HER2-low breast cancer patients after neoadjuvant chemotherapy.
Yingbo Shao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it